InvestorsHub Logo

db7

Followers 221
Posts 39774
Boards Moderated 0
Alias Born 09/02/2003

db7

Member Level

Re: Potse post# 1838

Tuesday, 12/31/2013 2:21:15 PM

Tuesday, December 31, 2013 2:21:15 PM

Post# of 2894
interesting commentary in this article re: wound care/regenerative...etc


http://seekingalpha.com/article/1922791-jason-napodano-positions-for-2014-biotech-m-a-growth-trend-to-continue?source=yahoo


JN = Jason Napodano fwiw


"

(SA): Drilling down a bit more now, what are the sub-sectors you're focused on for 2014?

(JN): Several regenerative medicine stocks may finally be coming of age. Every year investors tend to wonder if this is the year stem cell stocks perform well. I think you have to be selective and focus on stocks with near-term catalysts and plenty of cash on the books, but there are names within regenerative medicine I like. Specifically Neuralstem, Inc. (CUR). Neuralstem had a great 2013 (+130%), and I expect the run to continue in 2014. Investors can read about why I like Neuralstem in this article I wrote for the healthcare research website, PropThink, back in November 2013.

I think the wound care market is in for big changes in 2014.


"

-------------------------------------------------------------------

All posts are strictly my opinion and are not buy or sell recommendations.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.